Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial.
Mitsuya K, Akiyama Y, Iizuka A, Miyata H, Deguchi S, Hayashi N, Maeda C, Kondou R, Kanematsu A, Watanabe K, Ashizawa T, Abe Y, Ito I, Oishi T, Sugino T, Nakasu Y, Yamaguchi K.
Mitsuya K, et al. Among authors: abe y.
Anticancer Res. 2020 Nov;40(11):6473-6484. doi: 10.21873/anticanres.14669.
Anticancer Res. 2020.
PMID: 33109586
Clinical Trial.